News & Updates

Show Multimedia Only

Smoking tied to severe, frequent ocular symptoms in young people

11 Sep 2023

Among teens and young adults, users of both e-cigarettes and cigarettes are more likely to experience severe and frequent ocular symptoms than abstainers, as reported in a study.

Smoking tied to severe, frequent ocular symptoms in young people

11 Sep 2023

Can retinal thinning predict disability in MS?

07 Sep 2023 by

Retinal thinning predicts disability in patients newly diagnosed with relapsing multiple sclerosis (MS), an immune-mediated disease affecting the brain and spinal cord, in a new study presented at EAN 2023.

Can retinal thinning predict disability in MS?

07 Sep 2023

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Treatment with brolucizumab results in a longer interval between injections of antivascular endothelial growth factor (anti-VEGF) agents for most treatment-experienced eyes, especially those with shorter intervals before switching, while maintaining or improving visual acuity (VA), reports a study.

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023 by

Treatment with dexamethasone implant results in better outcomes for patients with persistent or recurrent uveitic macular edema (ME) at 12 weeks when compared with methotrexate or ranibizumab, a study has shown. The risk of intraocular pressure (IOP), however, is higher with dexamethasone, but elevations to levels of 30 mm Hg or more are rare.

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

New drug applications approved by US FDA as of 16-31 August 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

What is the leading cause of blindness in children?

31 Aug 2023

Retinopathy of prematurity (ROP) appears to be the leading cause of childhood blindness, reveals a recent study in the US. More than half of these blind patients have had a treatable cause of blindness.

What is the leading cause of blindness in children?

31 Aug 2023

Eye drops for myopia control in kids disappoint in US study

07 Aug 2023 by

Nightly administration of atropine 0.01% eye drops does little to slow myopia progression or axial elongation in a cohort of school-aged children in the US who have low-to-moderate myopia, as shown in a study.

Eye drops for myopia control in kids disappoint in US study

07 Aug 2023

High polygenic risk linked to earlier treatment initiation, escalation in glaucoma

02 Aug 2023

High glaucoma polygenic risk score (PRS) shows a significant association with earlier initiation or escalation of intraocular pressure (IOP)-lowering therapy, according to a study, noting the potential usefulness of genetic risk stratification in glaucoma.

High polygenic risk linked to earlier treatment initiation, escalation in glaucoma

02 Aug 2023

Original New Drug Application Approvals by US FDA (16-31 July 2023)

02 Aug 2023

New drug applications approved by US FDA as of 16-31 July 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 July 2023)

02 Aug 2023

Sight-threatening eye diseases tied to higher risk of suicide death

01 Aug 2023

In South Korea, the rate of suicide is particularly increased among individuals diagnosed with sight-threatening eye disease (STED) between 2010 and 2020, reveals a study.

Sight-threatening eye diseases tied to higher risk of suicide death

01 Aug 2023

News & Updates

Showing Ophthalmology articles

Showing

Specialty:

Smoking tied to severe, frequent ocular symptoms in young people

Smoking tied to severe, frequent ocular symptoms in young people

Can retinal thinning predict disability in MS?

Can retinal thinning predict disability in MS?

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Original New Drug Application Approvals by US FDA (16-31 August 2023)

What is the leading cause of blindness in children?

What is the leading cause of blindness in children?

Eye drops for myopia control in kids disappoint in US study

Eye drops for myopia control in kids disappoint in US study

High polygenic risk linked to earlier treatment initiation, escalation in glaucoma

High polygenic risk linked to earlier treatment initiation, escalation in glaucoma

Original New Drug Application Approvals by US FDA (16-31 July 2023)

Original New Drug Application Approvals by US FDA (16-31 July 2023)

Sight-threatening eye diseases tied to higher risk of suicide death

Sight-threatening eye diseases tied to higher risk of suicide death